Effect of amantadine and imipramine on immunological parameters of rats subjected to a forced swimming test

International Journal of Neuropsychopharmacology

Volumn 9, Issue 3, 2006, Pages 297-305

  Kubera, Marta ^a   Basta Kaim, Agnieszka ^a   Budziszewska, Bogusława ^a   Rogóz, Zofia ^a   Skuza, Grazyna ^a   Leśkiewicz, Monika ^a   Tetich, Magdalena ^a   Jaworska Feil, Lucylla ^a   Maes, Michael ^b   Lasoń, Władysław ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Amantadine; Corticosterone; Imipramine; Splenocyte proliferation

Indexed keywords

AMANTADINE; ANTIDEPRESSANT AGENT; CONCANAVALIN A; CORTICOSTERONE; IMIPRAMINE; INTERLEUKIN 10;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CYTOKINE PRODUCTION; DEPRESSION; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; FORCED SWIMMING TEST; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOLOGICAL PARAMETERS; IMMUNOPHARMACOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; STRESS;

AMANTADINE; ANIMALS; CELL PROLIFERATION; CORTICOSTERONE; CYTOKINES; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; IMIPRAMINE; IMMOBILIZATION; MALE; ORGAN SIZE; RATS; RATS, WISTAR; SPLEEN; SWIMMING; THYMUS GLAND;

EID: 33646864743     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145705005663     Document Type: Article

References (54)

1. Aoki FY, Sitar DS (1988). Clinical pharmacokinetics of amantadine hydrochloride. Clinical Pharmacokinetics 14, 35-51.
2. Audus KL, Gordon MA (1982). Characteristic of tricyclic antidepressant binding sites associated with murine lymphocytes from spleen. Journal of Immunopharmacology 4, 1-12.
3. Azpiroz A, Fano E, Garmendia L, Arregi A, Cacho R, Beitia G, Brain PF (1999). Effects of chronic mild stress (CMS) and imipramine administration, on spleen mononuclear cell proliferative response, serum corticosterone level and brain norepinephrine content in male mice. Psychoneuroendocrinology 24, 345-361. doi:10.1016/S0306-4530(98)00084-5.
4. Bachen EA, Manuck SB, Marsland AL, Cohen S, Malkoff SB, Muldoon MF, Rabin BS (1992). Lymphocyte subset and cellular immune response to a brief experimental stressor. Psychosomatic Medicine 54, 673-679.
5. Basso AM, Gioino G, Molin VA, Cancela LM (1999). Chronic amphetamine facilitates immunosuppression in response to a novel aversive stimulus: reversal by haloperidol pretreatment. Pharmacology, Biochemistry and Behavior 62, 307-314. doi:10.1016/S0091-3057(98)00166-X.
6. Bauer ME, Perks P, Lightman SL, Shanks N (2001). Restraint stress is associated with changes in glucocorticoid immunoregulation. Physiology and Behavior 73, 525-532. doi:10.1016/S0031-9384(01)00503-0.
7. Benbernou N, Esnault S, Shin HC, Fekkar H, Guenounou M (1997). Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway. Immunology 91, 361-368. doi:10.1046/j.1365-2567.1997.00260.X.
8. Brady LS, Whitfield HJ, Fox RJ, Gold PW, Herkenham M (1991). Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Journal of Clinical Investigation 87, 831-837.
9. Clark C, Woodson MM, Nagasawa HT (1991). Inhibition of lymphocyte proliferation by amantadine and its isomer, 2-aminoadamantane; impact on Lyt-2+ T cells while sparing L3T4+ T cells. Immunopharmacology 21, 41-50. doi:10.16/0162-3109(91)90006-K.
10. Clark C, Woodson MM, Winge VB, Nagasawa HT (1989). The antiviral drug amantadine has a direct inhibitory effect on T-lymphocytes. Immunopharmacology 18, 195-204. doi:10.1016/0162-3109(89)90017-9.
11. Connor TJ, Kelly JP, Leonard BE (1998). Forced swim test - induced endocrine and immune changes in the rat: effect of subacute desipramine treatment. Pharmacology Biochemistry and Behavior 59, 171-177. doi:10.1016/S0091-3057(97)00316-X.
12. Cox JH, Ford WL (1982). The migration of lymphocytes across specialized vascular endothelium. IV. Prednisolone acts at several points on the recirculation pathway of lymphocytes. Cellular Immunology 66, 407-422. doi:1016/0008-8749(82)90190-3.
13. Dhabhar FS, Miller AH, McEwen BS, Spencer RL (1995). Effects of stress on immune cell distribution. Dynamics and hormonal mechanisms. Journal of Immunology 54, 5511-5527.
14. Dietrich DE, Bode L, Spannhuth CW, Lau T, Huber TJ, Brodhun B, Ludwig H, Emrich HM (2000). Amantadine in depressive patients with Borna disease virus (BDV) infection: an open trial. Bipolar Disorder 2, 65-70.
15. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES (2000). The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacological Reviews 52, 595-638. doi:0031-6997/5204-0595$03. 00/0.
16. Fadda P, Pani L, Porcella A, Fratta W (1995). Chronic imipramine, L-sulpiride and mianserin decrease corticotropin releasing factor levels in the rat brain. Neuroscience Letters 192, 121-123. doi:10.1016/0304-3940(95)11612-Z.
17. Ferszt R, Kuhl K-P, Bode L, Severus EW, Winzer B, Berghofer A, Beelitz G, Brodhun B, Muller-Oerlinghausen B, Ludwig H (1999). Amantadine revisited: an open trial of amantadinesulfate treatment in chronically depressed patients with borna disease virus infection. Pharmacopsychiatry 32, 142-147.
18. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A (1991). IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. Journal of Immunology 146, 3444-3451.
19. Hasko G, Szabo C, Nemeth ZH, Salzman AL, Vizi ES (1998). Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice. Journal of Neuroimmunology 88, 57-61. doi:10.1016/S0165- 5728(98)00073-3.
20. Heuser IJE, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Dettling M, Yassouridis A, Holsboer F (1996). Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. American Journal of Psychiatry 153, 93-99.
21. Holsboer F, Barden N (1996). Antidepressants and hypothalamic-pituitary- adrenocortical regulation. Endocrine Reviews 17, 187-205.
22. Holsboer F, Gerken A, Stalla GK, Muller OA (1985). ACTH, cortisol and corticosterone output after ovine corticotrophin-releasing factor challenge during depression and after recovery. Biological Psychiatry 20, 276-286. doi:10.1016/0006-3223(85)90057-5.
23. Kouassi E, Boukhris W, Descotes J, Zukervar P, Li YS, Revillard, JP (1987). Selective T cell defects induced by dopamine. Administration in mice. Immunopharmacology and Immunotoxicology 9, 477-487.
24. Kronfol Z, Silva J, Greden J, Dembinski S, Gardner R, Carroll B (1983). Impaired lymphocyte function in depressive illness. Life Sciences 33, 241-247. doi:10.1016/0024-3205(83)90382-X.
25. Kubera M, Basta-Kaim A, Skowron-Cendrzak A, Mazur-Kolecka B, Roman A, Borycz J (1995). Effect of repeated amitriptyline administration to mice on the T lymphocyte proliferative activity and natural killer cell cytotoxicity. Polish Journal of Pharmacology 47, 321-326.
26. Kubera M, Basta-Kaim A, Wrobel A, Maes M, Dudek D (2004). Increased mitogen-induced lymphocyte proliferation in treatment resistant depression: a preliminary study. Neuroendocrinology Letters 25, 207-210.
27. Kubera M, Filip M, Basta-Kaim A, Nowak E, Budziszewska B, Tetich M, Holan V, Korzeniak B, Przegalinski E (2002). The effect of amphetamine sensitization on mouse immunoreactivity. Journal of Physiology and Pharmacology 53, 233-242.
28. Kubera M, Kenis G, Bosmans E, Ziȩba A, Dudek D, Nowak G, Maes M (2000). Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. Polish Journal of Pharmacology 52, 237-241.
29. Kubera M, Lin A-H, Kenis G, Bosmans E, van Bockstaele D, Maes M (2001a). Anti-inflammatory effects of antidepressants through suppression of the interferon-γ/interleukin-10 production ratio. Journal of Clinical Psychopharmacology 21, 199-206.
30. Kubera M, Maes M. (2000). Serotonin-immune interactions in major depression. In: Petterson P, Kordon C, Christen Y (Eds.), Neuro-immune Interactions in Neurologic and Psychiatric Disorders (pp. 79-87). Berlin, Heidelberg: Springer-Verlag.
31. Kubera M, Maes M, Holan V, Basta-Kaim A, Roman A, Shani J (2001b). Prolonged desipramine treatment increases the production of interlekin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of depression. Journal of Affective Disorders 63, 171-178. doi:10.1016/S0165-0327(00)00182-8.
32. Kubera M, Symbirtsev A, Basta-Kaim A, Borycz J, Roman A, Papp M, Claesson M (1996). Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression. Polish Journal of Pharmacology 48, 503-506.
33. Leclerc C (1996). Interleukin-10. In: Cavaillon JM (Ed.), Les Cytokines (pp. 241-252). Paris: Masson.
34. Lysle D, Cunnick J, Rabin B (1990). Stressor-induced alteration of lymphocyte proliferation in mice: evidence for enhancement of mitogenic responsiveness. Brain Behavior and Immunity 4, 269-277. doi:10.1016/0889- 1591(90)90031-K.
35. Madden KS, Felten SY, Felten DL, Sundaresan PR, Livnat S (1989). Sympathetic neural modulation of the immune system. I. Depression of T cell immunity in vivo and vitro following chemical sympathectomy. Brain Behavior and Immunity 3, 72-89. doi:10.1016/0889-1591(89)90007-X.
36. Madden KS, Moynihan JA, Brenner GJ, Felten SY, Felten DL, Livnat S (1994). Sympathetic nervous system modulation of the immune system. III. Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy. Journal of Neuroimmunology 49, 77-87. doi:10.1016/0165-5728(94)90183-X.
37. Maj J, Rogoz Z (2000). Synergistic effect of amantadine and imipramine in the forced swimming test. Polish Journal of Pharmacology 52, 111-114.
38. Maslinski W, Laskowska-Bozek H, Ryzewski J (1992). Nicotinic receptors of rat lymphocytes during adjuvant polyarthritis. Journal of Neuroscience Research 31, 336-40.
39. Masuda Y, Kondoh M, Suzuki M, Ohnuma S, Shimizu T, Hishikawa T (1995). Participation of dopamine and norepinephrine in the secretion of interleukin-2 and interleukin-6 from the spleen of mice in different immune responses. Medical Science Research 23, 851-852.
40. Murphy BEP (1997). Antiglucocorticoid therapies in major depression: a review. Psychoneuroendocrinology 22, S125-S133.
41. Porsolt RD, Anton G, Blavet N, Jalfre M (1978). Behavioural despair in rats: a new model sensitive to antidepressant treatments. European Journal of Pharmacology 47, 379-391. doi:10.1016/0014-2999(78)90118-8.
42. Ramer-Quinn DS, Baker RA, Sanders VM (1997). Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. Journal of Immunology 159, 4857-4867.
43. Rinner I, Schauenstein K, Mangge H, Porta S, Kvetnansky R (1992). Opposite effects of mild and severe stress on in vitro activation of rat peripheral blood lymphocytes. Brain Behavior and Immunity 6, 130-140. doi:10.1016/0889-1591(92)90013-E.
44. Rogoz Z, Dziedzicka-Wasylewska M, Daniel WA, Wojcikowski J, Dudek D, Wrobel A, Zieba A (2004a). Effects of joint administration of imipramine and amantadine in patients with drug-resistant unipolar depression. Polish Journal of Pharmacology 56, 735-742.
45. Rogoz Z, Skuza G, Kuśmider M, Wójcikowski J, Kot M, Daniel WA (2004b). Synergistic effect of imipramine and amantadine in the forced swimming test in rats. Behavioral and pharmacokinetic studies. Polish Journal of Pharmacology 56, 179-185.
46. Rogoz Z, Skuza G, Maj J, Danysz W (2002). Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats. Neuropharmacology 42, 1024-1030. doi:10.1016/S0028- 3908(02)00055-2.
47. Sanders VM, Straub RH (2002). Norepinephrine, the beta-adrenergic receptor, and immunity. Brain Behavior and Immunity 16, 290-332. doi:10.1006/brbi.2001.0639.
48. Satoh T, Yamada K, Tsuboi M (1985). Effect of imipramine on serum corticosterone levels in forced swimming rats. Research Communications in Psychology and Behavior 10, 235-238.
49. Sluzewska A (1999). Indicators of immune activation in depressed patients. In: Dantzer A, Yirmia R (Eds.), Cytokines: Stress and Depression (pp. 59-73). New York: Kluwer Academic/Plenum Publishers.
50. Sluzewska A, Rybakowski J, Sobieska M, Bosmans E, Pollet H, Wiktorowicz K (1996). Increased levels of alpha-1-acid glycoprotein and interleukin-6 in refractory depression. Depression 39, 149-155.
51. Stefansky V, Engler H (1998). Effects of acute and chronic social stress on blood cellular immunity in rats. Physiology and Behavior 64, 733-741. doi:10.1016/S0031-9384(98)00127-9.
52. Swanson MA, Lee WT, Sanders VM (2001). IFN-gamma production by Th1 cells generated from naive CD4+ T cells exposed to norepinephrine. Journal of Immunology 166, 232-240.
53. Szelenyi J, Selmeczy Z (2002). Immunomodulatory effect of antidepressants. Current Opinion in Pharmacology 2, 428-432. doi:10.1016/S1471-4892(02)00173-X.
54. Yamada K, Horita Y, Tsuboi M (1989). Effects of repeated administration of antidepressants on swimming time and corticosterone levels in forced swimming rats. Research Communications in Psychology and Behavior 14, 253-256.